Assessment of lymph nodes in patients with Endometrial Cancer

The effect of dye injection to the cervix on detection of tumoral lymph nodes in patients with Endometrial Cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201412154868N5

Enrollment

Registered

2015-06-09

Start date

2014-06-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial Cancer. Malignant neoplasm of corpus uteri

Interventions

Ingection of methylen blue to the cervix and uterin fundus befor surgery.

Diagnosis

Ingection of methylen blue to the cervix and uterin fundus befor surgery

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with pathologically confirmed endometrial cancer candidate for systemic lymphadenectomy. Exclusin griteria: high risk anestasia

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Presence and Number of Sentinel Nodes. Timepoint: 5 minutes after injection of dye. Method of measurement: inspection.	—

Secondary

Measure	Time frame
Sentinel lymph Node Methastasis. Timepoint: 30 days after surgery. Method of measurement: Pathologic assesment.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKhadijeh Elmizadeh

Tehran University of Medical Science

khelmizadeh@qums.ac.ir+98 21 6658 1610

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026